Skip to content

The Medicines Advice Service Evaluation

The Medicines Advice Service: A Randomised Controlled Trial of a Pharmacy-based Telephone Intervention to Support Patients Taking Medication for a Long-term Condition

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01864239
Enrollment
677
Registered
2013-05-29
Start date
2012-11-30
Completion date
2014-09-30
Last updated
2015-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemias, Type 2 Diabetes

Keywords

Adherence

Brief summary

The purpose of this study is to find out whether talking to a pharmacist on the telephone can help to support people taking medicine for a long-term condition.

Detailed description

Non-adherence to medication is common and although some interventions have shown promise in improving adherence, the findings are inconsistent. This randomised controlled trial aims to test the effectiveness of a pharmacy-based telephone intervention compared to usual care on medication adherence and health outcomes in patients taking medicines for a long-term condition.

Interventions

OTHERMedicines Advice Service

The intervention consists of: 1. Telephone consultations with a pharmacist 2. Follow-up tailored written information 3. A medicine reminder chart

Sponsors

Pharmacy2U
CollaboratorUNKNOWN
University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients prescribed medication(s) for at least one of the following conditions: type 2 diabetes, hyperlipidemia

Exclusion criteria

* Patients living outside of England * Patients with no access to a telephone * Patients under the age of 18 * Patients unable to give written informed consent * Patients on drugs for dementia * Patients showing signs of dementia or cognitive impairment in conversation * Patients with substantial hearing or sight impairment * Patients whose medications are ordered by a caregiver/family member * Patients with insufficient English to take part in the telephone intervention * Patients living with someone already taking part in the study * Patients newly prescribed a medication for the conditions listed in the inclusion criteria

Design outcomes

Primary

MeasureTime frame
Self-reported medication adherence6 months

Secondary

MeasureTime frameDescription
Prescription refill adherenceBaseline, 6 months and 12 months
Self-reported medicine-related problems and concernsBaseline, 3 months and 6 monthsMedicine-related problems and concerns will be assessed in a self-report questionnaire.
Beliefs about MedicinesBaseline, 3 months and 6 monthsBeliefs about medicines will be assessed in a self-report questionnaire using the Beliefs About Medicines Questionnaire (BMQ) (Horne et al. 1999).
HbA1cBaseline and 6 months
Serum Cholesterol LevelsBaseline and 6 months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026